Navigation Links
Royalty Pharma Announces Proposal To Acquire Elan
Date:2/25/2013

of RP Management, LLC to verify this information).  To the best of the knowledge and belief of the member of RP Management, LLC (having taken all reasonable care to ensure that such is the case), the information contained in this announcement for which he accepts responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

J.P. Morgan, together with its affiliate J.P. Morgan Limited (which is authorised and regulated by the Financial Services Authority in the United Kingdom), is acting exclusively for Royalty Pharma and for no one else in connection with the matters described in this announcement and is not, and will not be, responsible to anyone other than Royalty Pharma for providing the protections afforded to clients of J.P. Morgan, or for providing advice in connection with the matters described in this announcement.

Rule 8 – Dealing Disclosure RequirementsUnder the provisions of Rule 8.3 of the Irish Takeover Rules, if any person is, or becomes, "interested" (directly or indirectly) in one per cent. or more of any class of "relevant securities" of Elan, all "dealings" in any "relevant securities" of Elan (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by not later than 3.30 pm (Dublin time) on the "business day" following the date of the relevant transaction. This requirement will continue until the date on which the Possible Offer becomes effective, lapses or is otherwise withdrawn or on which the Offer Period otherwise ends. If two or more persons co-operate on the basis of any agreement, either express or tacit, either oral or written, to acquire an "interest" in "relevant securities" of Elan, they will be deemed to be a single person for the purpose of Rule 8.3 of the Irish Takeover Rules.

Under the provisions of Rule 8.1
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
3. Health Outcomes Liaisons (HOLs) Serve as Key Bridge between Pharmaceutical Sector and Managed Care Groups
4. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
5. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
7. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
8. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
9. Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
10. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015  AVACEN, Inc. announced today the ... patent covering the medical technology platform supporting its unique Dry ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... methods patent no. 9,066,781 - Methods And Apparatus For Therapeutic ... AVACEN and specific methods of use, referred to by the ...
(Date:7/1/2015)... , July 1, 2015 Rock Creek ... company focused on chronic inflammatory disease and neurologic disorders, ... principle study with anatabine citrate, the Company,s lead compound. ... dose of anatabine citrate can significantly inhibit the activation ... The Company is developing this compound in a Phase ...
(Date:7/1/2015)... 2015 Egalet Corporation (Nasdaq: EGLT ... focused on developing, manufacturing and marketing innovative pain ... president and chief executive officer, is scheduled to ... provide an update on Egalet,s marketed product ... approved product OXAYDO ™ (oxycodone HCI, USP) ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... Sinovac Biotech Ltd. (NASDAQ: SVA ), a ... the positive top-line results from its phase II clinical ... 71 (EV71), which causes hand, foot and mouth disease ... vaccine showed a good immunogenicity and a favorable safety ...
... -- China Sky One Medical, Inc. ("China Sky One" or ... integrated pharmaceutical company producing over-the-counter drugs in the People,s Republic ... quarter of 2011. Third Quarter ... decreased 26.6% year-over-year to $26.6 million The Company marketed ...
Cached Medicine Technology:Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 2Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 3Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease 4China Sky One Medical Announces Third Quarter 2011 Results 2China Sky One Medical Announces Third Quarter 2011 Results 3China Sky One Medical Announces Third Quarter 2011 Results 4China Sky One Medical Announces Third Quarter 2011 Results 5China Sky One Medical Announces Third Quarter 2011 Results 6China Sky One Medical Announces Third Quarter 2011 Results 7China Sky One Medical Announces Third Quarter 2011 Results 8China Sky One Medical Announces Third Quarter 2011 Results 9China Sky One Medical Announces Third Quarter 2011 Results 10China Sky One Medical Announces Third Quarter 2011 Results 11China Sky One Medical Announces Third Quarter 2011 Results 12China Sky One Medical Announces Third Quarter 2011 Results 13China Sky One Medical Announces Third Quarter 2011 Results 14China Sky One Medical Announces Third Quarter 2011 Results 15China Sky One Medical Announces Third Quarter 2011 Results 16China Sky One Medical Announces Third Quarter 2011 Results 17China Sky One Medical Announces Third Quarter 2011 Results 18
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Ralph Garramone introduced CoolSculpting Plus, an advanced approach to body contouring. ... up to 44%. , About the basic CoolSculpting procedure:, The CoolSculpting ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... their products, services, channels and business models. To help manage the increasing demand ... addition of Mark Benkendorf as SVP of Strategic Engagements. , Benkendorf is a ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Sir Fazle Hasan ... World Food Prize today. Sir Fazle has been recognised for his outstanding contribution to ... , Ambassador Ken Quinn, President of the World Food Prize Foundation, announced this year’s ...
(Date:7/1/2015)... ... 01, 2015 , ... SuiteRx, innovative leaders in pharmacy performance ... operations, announces the most recent positioning of SuiteRx CEO, Nicholas Zener Pharm. D., ... the Venetian Las Vegas, Nevada. During this event, SuiteRx will be highlighting ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 , ... ... $100,000 from the New York Community Trust. The grant will allow CCF to improve ... sharing proven practices. , CCF was formed to respond to many changes in New ...
Breaking Medicine News(10 mins):Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 2Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3
... April 25, 2012 Preliminary Research presented today ... Biology (FASEB) Conference in San Diego demonstrates that ... mashed) is not associated with obesity, type 2 ... of systemic inflammation once potential confounding factors are ...
... be able to access hidden wisdom in the brain ... and safety, UCLA neuroscientists report in the first study ... will respond to advertisements. Thirty smokers ... three advertising campaigns, which all ended by showing the ...
... life and death for very low birth weight infants, according ... Nursing and released today in JAMA , The ... comprehensive study of 72,235 infants born in 558 hospitals across ... hospitals with the Magnet credential were less likely to die, ...
... a bit of a puzzle. Representing only 10 percent of ... and persecuted across history. The word "sinister" even derives from ... report that a high degree of cooperation, not something odd ... left-handedness. They developed a mathematical model that shows the low ...
... April 25 (HealthDay News) -- A lack of support following ... a loved one, abuse and sexual assault can trigger eating ... disorders said even changing schools or jobs could trigger eating ... of Minnesota researchers. The study included 26 women and ...
... Reporter , WEDNESDAY, April 25 (HealthDay News) -- So, what ... as in Holy Grail, because a Florida gynecologist contends that he ... Dr. Adam Ostrzenski said, he located the elusive source of female ... a paper published online April 25 in The Journal of ...
Cached Medicine News:Health News:Which ads are winners? Your brain knows better than you do 2Health News:Which ads are winners? Your brain knows better than you do 3Health News:Which ads are winners? Your brain knows better than you do 4Health News:Choosing the right hospital may save your baby's life 2Health News:Shedding light on southpaws 2Health News:Life Transitions May Trigger Eating Disorders 2Health News:Has the 'G-Spot' Been Confirmed at Last? 2Health News:Has the 'G-Spot' Been Confirmed at Last? 3
... The electronic, motorized rotary ... all applications of paraffin, ... hard specimens in clinical, ... These instruments display extra-ordinary ...
... new face-lifted Leica RM2125 microtome comes in ... and Leica RM2125 RT. All RM2125 versions ... avoid debris entering the precision micrometer feeding ... a two-step trimming function and specimen retraction ...
... The Leica SM2500 large scale heavy-duty sectioning system ... large sectioning techniques a real working animal. ... and hard materials such as bone or teeth ... sectioned. The wide range of accessories, specially designed ...
... Designed for biomedical and industrial applications, the ... a variety of applications in all laboratories ... to be sectioned. Its sturdy construction lends ... The safety features of the system, such ...
Medicine Products: